Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 2936Neoplasms 2634Lung Neoplasms 1371Colorectal Neoplasms 1332Prostatic Neoplasms 1216Carcinoma, Non-Small-Cell Lung 1080Carcinoma, Hepatocellular 784Stomach Neoplasms 721Pancreatic Neoplasms 704Ovarian Neoplasms 586Colonic Neoplasms 534Uterine Cervical Neoplasms 497Head and Neck Neoplasms 496Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 423Neoplasm Metastasis 418Brain Neoplasms 405Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Urinary Bladder Neoplasms 387Leukemia, Myeloid, Acute 387Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 313Recurrence 298Disease 275

Interventions

Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Heart Failure, Systolic × Clear all
NCT02018497 2023-09-21

ESSENTIAL

CES University

Unknown
5,000 enrolled

Atrial Fibrillation, Autonomic Nervous System Diseases, Ischemic Attack, Transient, Cerebrovascular Disorders, Coronary Disease, Depression, Diabetes Mellitus, Fibromyalgia, Hypotension, Neoplasms, Syncope, Fatigue Syndrome, Chronic, Panic Disorder, Syncope, Vasovagal, Acute Coronary Syndrome, Heart Failure, Systolic, Heart Failure, Diastolic

NCT02026505 2019-03-13

Evaluation of Cardiotoxic Effects of Bortezomib

Oregon Health and Science University

Completed
11 enrolled
Plasma cell

Multiple Myeloma, Heart Failure, Systolic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡